09 May 2018 Research
Sharing this exciting news: a treatment advance for childhood leukaemia
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades.
“We are excited at this breakthrough in the treatment for childhood leukaemia. CAR-T cell therapy gives those children who do not respond to chemotherapy treatment a real chance of a long-term cure. We welcome this significant step forward which will give hope to families whose children are affected by leukaemia.”
Dr Maria Gilleece, Director, Yorkshire Blood and Marrow Transplant Programme and a member of the Leukaemia UK Medical Panel.
Related posts
16 November 2022
Cost of Living with Leukaemia Fund launches
Leukaemia Care and Leukaemia UK have launched a new financial support service, the Cost of Living with Leukaemia Fund, in response to the cost of living crisis in the UK….
31 October 2022
Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy
Blood cancer research charity, Leukaemia UK, has hired Anna Wilson and Lizzie Afonso from housing and homelessness charity, Shelter, to job-share its new Communications Director role. This is the first…
18 May 2022
World Blood Cancer Day interview with Dr Pramila Krishnamurthy
On 28th May the global blood cancer community comes together to mark World Blood Cancer Day, this campaign calls for support of those with blood cancer and encourages people to become stem cell donors.
21 June 2023
Prestigious jointly-funded fellowship could be catalyst for myeloma prevention
Dr Louise Ainley, University College London, has been awarded a Clinical Research Training Fellowship – jointly funded with the Medical Research Council. The three-year project is set to investigate which…